SOF + PEG-IFN ï -2a + RBV Open-label Single arm ≥ 18 years Chronic HCV infection Genotype 1, 4, 5 or 6 Treatment-na¯ve HCV RNA ≥ 10,000 IU/ml Compensated
Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study - The Lancet Haematology
![PDF] An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bd292c301c51a1f717d8f0c14788762c69120a87/4-Figure1-1.png "PDF] An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results. | Semantic Scholar")
PDF] An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results. | Semantic Scholar
Hanan Goldberg on Twitter: "Dr. De Wit presenting Keynote 057 study results, a single arm open label study of pembrolizumab in NMIBC patients unresponsive to BCG, demonstrating complete response rates of 38.8%!
PLOS ONE: Investigation of safety and efficacy of the new more thermostable formulation of Flolan (epoprostenol) in Japanese patients with pulmonary arterial hypertension (PAH)—An open-label, single-arm study
A Phase III, Open-Label, Single-Arm Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters - Journal of Vascular and Interventional Radiology
Fillable Online impaactnetwork A Phase I/II Open-Label, Single-Arm Study to Evaluate the Fax Email Print - pdfFiller
Rationale and study design of MOTION: A phase 4, prospective, single-arm, open-label study to measure outcomes in patients with pulmonary arterial hypertension not on active treatment - Respiratory Medicine
A Single Center Open Label Single Arm Study Evaluating Efficacy and Safety of Skin Adhesive EpinexusTM in Surgical Patients
Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open -label, phase II study (CheckMate 172) - European Journal of Cancer
A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis - Gynecologic Oncology
An open label, single arm, prospective clinical study to evaluate liver safety and tolerability of PUREMERIC™ (standardized extract from Curcuma longa) in healthy subjects - ScienceDirect
An Open-Label, Single-Arm, Efficacy Study of Tranexamic Acid in Adolescents with Heavy Menstrual Bleeding - Journal of Pediatric and Adolescent Gynecology
Open-label, multi-center, non-randomized, single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies, on supportive care - Cytotherapy
CONSORT flowchart for A single-arm, open-label, phase 2 clinical trial... | Download Scientific Diagram
A multicenter, open-label, uncontrolled, single-arm phase 2 study of tirabrutinib, an oral Bruton's tyrosine kinase inhibitor, in pemphigus - Journal of Dermatological Science
Efficacy and Safety of Intrathecal Pemetrexed Combined With Dexamethasone for Treating Tyrosine Kinase Inhibitor-Failed Leptomeningeal Metastases From EGFR-Mutant NSCLC—a Prospective, Open-Label, Single-Arm Phase 1/2 Clinical Trial (Unique Identifier ...
Stereotactic body radiation therapy with sequential S-1 for patients with locally advanced pancreatic cancer and poor performance status: An open- label, single-arm, phase 2 trial - Radiotherapy and Oncology
Acalabrutinib monotherapy for treatment of chronic lymphocytic leukaemia (ACE-CL-001): analysis of the Richter transformation cohort of an open-label, single-arm, phase 1–2 study - The Lancet Haematology
The study was design as single-arm open-label trial consisting of a 14... | Download Scientific Diagram
New approaches to clinical trials: Adaptive designs - EUPATI Toolbox
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial - The Lancet Oncology
Evaluation of apremilast in chronic pruritus of unknown origin: A proof‐of‐concept, phase 2a, open‐label, single‐arm clinical trial - Clark - 2020 - Health Science Reports - Wiley Online Library
Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study - The Lancet Respiratory Medicine
Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study - European Journal of Cancer
Study 079 An OpenLabel SingleArm Phase 2 Trial
